$CBIS Dr. Herman reflected, "During the roundtabl

$CBIS Dr. Herman reflected, "During the roundtable discussion after our presentation, we had the opportunity to discuss potential pre-clinical, and clinical research programs and goals with the scientists at DF/HCC . Our drug development targeting will be executed by the new partnership and is expected to alter the dynamics of phyto-pharmaceutical development, particularly in the areas of clinical trial design and program implementations. Our discussions of these focal areas with Dr. Wil Ngwa and his colleagues were incisive and very positive, and we have started the process of planning a series of exciting and mutually beneficial partnership opportunities."

https://finance.yahoo.com/news/harvard-direct...21684.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!